Navigation Links
First Ever Patch Drug To Treat Parkinsons Symptoms Approved

The U.S. Food and Drug administration on Wednesday approved a new patch-drug, the first ever medicine to treat the symptoms of Parkinson's disease . Known by the name Neupro, the once-daily patch is manufactured by Schwarz Pharma AG. The patch contains a drug called rotigotine, which has not been sold before in the United States.

Parkinsons disease (PD) is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills and speech. It is characterized by muscle rigidity, tremor, a slowing of physical movement and, in extreme cases, a loss of physical movement.

In a healthy brain, certain brain cells produce a chemical called dopamine, which helps the brain coordinate the body's movements while in the patients who suffer from Parkinson's, dopamine-producing brain cells cannot survive. Dopamine is crucial for the communication between cells that control muscle movement hence the sufferers of PD are often seen trembling.

Accordingly, the rotigotine present in the Neupro patch works by activating dopamine receptors in the brain, imitating the neurotransmitter's effect. The FDA determined the effectiveness of Neupro's by three studies that included 1,154 patients with early Parkinson's disease who were not taking other Parkinson's medications.

Rotigotine is a member of a class of drugs called dopamine agonists, which mimic dopamine's effects.

Other Parkinson's disease drugs are given orally. Those drugs are effective, but some patients experience a wearing-off effect at the end of each dose. The Parkinson's patch is designed to solve that problem.

However, the patch also has some side effects that include skin reactions at the patch site, dizziness, nausea, vomiting, drowsiness and insomnia. Also, the patient using this patch can experience a sudden onset of sleep while doing some activities like driving or operating machinery. Other side effects also include hallucinat ions and decreased blood pressure when standing up.

An estimated 1 million people in the U.S. have Parkinson's, with an additional 60,000 cases diagnosed each year.


'"/>




Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. First human clone is near
4. First Artificial Heart patient has Major setback
5. First head-to-head trials of once weekly Fosamax and Actonel therapies
6. WHO Declares Vietnam First Country to Control SARS
7. Russia Reports First SARS Case
8. Hope for First New Melanoma Treatment in Decades
9. First global SARS meet opens
10. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
11. Hyderabad To Have Asia’s First Catheter Making Uni
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: